REGENXBIO(RGNX) - 2023 Q4 - Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Patrick Christmas – Chief Legal Officer Ken Mills – Chief Executive Officer Steve Pakola – Chief Medical Officer Vit Vasista – Chief Financial Officer Conference Call Participants Gena Wang – Barclays Gospel Enyindah-Asonye – Morgan Stanley Alec Stranahan – Bank of America Annabel Samimy – Stifel Lisa Walter – RBC Capital Markets Mani Foroohar – Leerink Partners Operator Good day, and thank you fo ...